Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Medical Oncology|March 12, 2019
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumorsGloria Ravegnini, Giulia Sammarini, César Serrano, et al.
The British Journal of Ophthalmology|April 27, 2000
Lupus anticoagulant positivity in insulin dependent diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy?C Giusti, R Schiaffini, D Bosco, et al.
Autophagy|January 6, 2017
Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosisGloria Ravegnini, Giulia Sammarini, Margherita Nannini, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1997
Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitusP Gargiulo, R Schiaffini, D Bosco, et al.
Biochimica Et Biophysica Acta|March 27, 2013
A high-throughput assay for the detection of Tyr-phosphorylated proteins in urine of bladder cancer patientsA Khadjavi, A Notarpietro, F Mannu, et al.
International Journal of Colorectal Disease|June 9, 2004
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabineG Brandi, M A Pantaleo, C Calabrese, et al.
Cancer Chemotherapy and Pharmacology|January 20, 2009
To widen the setting of cancer patients who could benefit from metronomic capecitabineMargherita Nannini, Elisabetta Nobili, Roberto Di Cicilia, et al.
Oncology Reports|May 9, 2009
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review)Alessandra Maleddu, Maria A Pantaleo, Margherita Nannini, et al.
International Journal of Molecular Sciences|July 18, 2015
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA AnalysisGloria Ravegnini, Margherita Nannini, Giulia Sammarini, et al.
Cancer Treatment Reviews|December 7, 2007
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapyM A Pantaleo, M Nannini, A Maleddu, et al.
Pageof 12